Medicare, Medicaid Coverage Of Obesity Drugs Would Add $40bn In Government Spending

The proposal states that Part D plans could define "obesity" for coverage determination, but CMS said overly restrictive criteria would be inconsistent with formulary review requirements and step-therapy would not be allowed.